2-[18F]-fluoroisonicotinic acid hydrazide: Biological evaluation in an acute infection model

Applied Radiation and Isotopes

Volumn 60, Issue 6, 2004, Pages 839-843

  Amartey, J K ^a   Esguerra, C ^a   Al Otaibi, B ^a   Parhar, R S ^a   Al Jammaz, I ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

2 18F fluoroisonicotinic acid hydrazide; E. coli infection and inflammation detection; Fluorine 18

Indexed keywords

CATALYSTS; ESCHERICHIA COLI; ORGANIC ACIDS; PHASE TRANSITIONS; RADIOACTIVE TRACERS;

PHASE TRANSFER CATALYSTS; RADIOCHEMICALS;

RADIOISOTOPES;

2 FLUOROISONICOTINIC ACID HYDRAZIDE F 18; ACETONITRILE; ETHER; HYDRAZINE; ISONICOTINIC ACID; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; CATALYST; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; FLUORINATION; IN VITRO STUDY; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RADIOCHEMISTRY; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FLUORINE RADIOISOTOPES; HUMANS; HYDRAZINES; INFECTION; ISONICOTINIC ACIDS; MICE; MICE, INBRED BALB C; TUBERCULOSIS, PULMONARY;

EID: 1942468907     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.01.009     Document Type: Article

References (16)

1. 18F]-fluoroisonicotinic acid hydrazide and initial biological evaluation. Nucl. Med. Biol. 29:2002;801-807
2. Bishburg E., Sunderman G., Reichman L.B., Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann. Intern. Med. 105:1986;210-213
3. Boice J.D., Fraumeni J.F. Late effects following isoniazid therapy. Am. J. Public Health. 70:1980;987-992
4. Chang A.B., Grimwood K., Harvey A.S., Rosenfeld J.V., Olinsky A. Central nervous system tuberculosis after resolution of miliary tuberculosis. Pediatr. Infect. Dis. J. 17:1998;519-523
5. Del Brutto O.H., Mosquera A. Brainstem tuberculoma mimicking glioma. the role of antituberculous drugs as a diagnostic tool Neurology. 52:1999;210-211
6. Eide F.F., Gean A.D., So Y.T. Clinical radiographic findings in disseminated tuberculosis of the brain. Neurology. 43:1993;1427-1429
7. Farrell V.J. Brain stem tuberculoma in adult patients. diagnosis and treatment Surg. Neurol. 34:1990;383-389
8. Gillis C.N. Pharmacological aspects of metabolic processes in the pulmonary microcirculation. Annu. Rev. Pharmacol. Toxicol. 26:1986;183-200
9. Goble M., Iseman M.D., Madsen L.A., Waite D., Ackerson L., Horsburgh C.R. Treatment of 117 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N. Engl. J. Med. 328:1993;527-532
10. Jenne J.W., Beggs W.H. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol and rifampin. Am. Rev. Respir. Dis. 107:1973;1013-1021
11. Lacy M.K., Lu W., Xu X., Tessier P.R., Nicolau D.P., Quintiliani R., Nightingale C.H. Pharmacodynamic comparisons of levofloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob. Agents Chemother. 43:1999;672-677
12. Mandell G.L., Sande M.A. Drugs used in the chemotherapy of tuberculosis and leprosy. Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 1985;McMillan, New York. (Chapter 53)
13. Mdluli K., Slayden R.A., Zhu Y., Ramaswamy S., Pan X., Mead D., Crane D.D., Musser J.M., Barry C.E. Inhibition of a mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science. 280:1998;1607-1610
14. Pernaute R.S., Berciano J., Rebollo M., Pascual J. Intramedullary tuberculoma of the spinal cord with syringomyelia. Neuroradiology. 38:1996;S105-S106
15. 124I]- iodoisonicotinic acid hydrazide-potential radiotracers for tuberculosis. Appl. Radiat. Isot. 41:1991;215-220
16. Sydel J.K., Schaper K.J., Wempe E., Cordes H.P. Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type. J. Med. Chem. 19:1976;483-492